A Trial to Assess the Effect of High Nitrogen Intake in Critically Ill Patients

May 23, 2020 updated by: Ming Zhong, Shanghai Zhongshan Hospital

The Efficacy and Safety of High Nitrogen Intake in Critically Ill Patients: a Randomized and Controlled Trial

The patients with sepsis are in high risk of malnutrition, which could contribute to infection, difficulty in weaning from ventilators. The investigators speculate whether nutrition therapy with high nitrogen could attenuate the malnutrition status and improve the outcome in these sepsis patients. In this prospective Randomized Controlled Trial, the investigators aim to compare high nitrogen intake with conventional nitrogen supply which were recommended in guidelines.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

89

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200032
        • Division of Critical Care Medicine: Zhongshan Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • need mechanical ventilation for more than 2 days
  • mean blood pressure more than 60mmHg
  • predicted ICU stay more than 7 days
  • tolerance of parenteral or enteral nutrition

Exclusion Criteria:

  • irreversible status of primary disease
  • any history of malnutrition before enrollment
  • history of steroid cortisol administration
  • severe liver dysfunction (Child-Pugh Score C)
  • pregnancy
  • refuse to enrollment
  • re-admission to ICU and has been enrolled during former admission to ICU

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High Nitrogen
In this arm, daily nitrogen supply is as much as 2.5-3.0 g per kilogram (lean mass weight)
Nitrogen supply could be administered through amino acid in parenteral nutrition, proteins in enteral nutrition.
Active Comparator: conventional nitrogen
In this arm, daily nitrogen supply is 1.2-1.5g per kilogram (lean mass weight) as recommended by ESPEN guideline
Nitrogen supply could be administered through amino acid in parenteral nutrition, proteins in enteral nutrition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
all cause mortality
Time Frame: 28 days
28 days
all cause mortality
Time Frame: 90 days
90 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
duration on ventilators
Time Frame: patients enrolled will be followed for the duration of mechanical ventilation, an expcected average of 4 weeks
patients enrolled will be followed for the duration of mechanical ventilation, an expcected average of 4 weeks
ICU stay
Time Frame: patients enrolled will be followed for length of ICU stay, an expected average of 6 weeks
patients enrolled will be followed for length of ICU stay, an expected average of 6 weeks
infection incidence rate
Time Frame: 28 days
Details of infection includes pneumonia, catheter-related blood stream infection, urinary tract infect, et al. Diagnosis of infection accords to symptoms, lab tests, imaging measurements and bacterial cultures.
28 days
Liver function and renal function
Time Frame: on 1st. day, 3rd. day, 7th. day, 14th. day, 21st. day, 28th. day after enrollment
Liver function is assessed through serum bilirubin and liver enzyme, renal function is assessed through serum urea nitrogen and creatinine.
on 1st. day, 3rd. day, 7th. day, 14th. day, 21st. day, 28th. day after enrollment
diameter of midpoint of musculus rectus femoris
Time Frame: on 28th. day or endpoint of the trial
diameter of the muscle is measured with percutaneous ultrasound
on 28th. day or endpoint of the trial
serum concentration of albumin, pre albumin, retinaldehyde binding protein, transferrin
Time Frame: on 7th. day , 14th. day, 21st. day, 28th. day after enrollment
on 7th. day , 14th. day, 21st. day, 28th. day after enrollment
change of body composition
Time Frame: on 7th.day, 14th.day, 21st.dat, 28th.day after enrollment
on 7th.day, 14th.day, 21st.dat, 28th.day after enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2015

Primary Completion (Actual)

January 1, 2020

Study Completion (Actual)

May 1, 2020

Study Registration Dates

First Submitted

March 30, 2014

First Submitted That Met QC Criteria

April 3, 2014

First Posted (Estimate)

April 8, 2014

Study Record Updates

Last Update Posted (Actual)

May 27, 2020

Last Update Submitted That Met QC Criteria

May 23, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • HiNiCi

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critically Ill

Clinical Trials on nitrogen supply

Subscribe